Plus, news about Incyte, Carisma Therapeutics, Idorsia, Leap Therapeutics, Enterome, Merck, Forte Biosciences, Enzon and Viskase:
Formation Bio licenses JAK/SYK inhibitor to Sanofi: The startup said the deal could be worth ...
↧